Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global and United States Hazardous Drug Compounding Systems Market Report & Forecast 2024-2030

Global and United States Hazardous Drug Compounding Systems Market Report & Forecast 2024-2030

Industry: Medical Devices & Consumables

Published Date: 2024-08-03

Pages: 134 Pages

Report ld: 3271822

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Hazardous Drug Compounding Systems refer to specialized procedures, equipment, and facilities designed to safely handle, prepare, and store medications classified as hazardous. These systems are crucial in healthcare settings, such as pharmacies and hospitals, where potent drugs like chemotherapy agents, antivirals, hormones, and other medications that pose significant risks to health workers and patients are prepared. The primary goal is to minimize exposure to these dangerous substances through stringent controls and protocols, including the use of ventilated cabinets, closed-system transfer devices, personal protective equipment, and rigorous environmental monitoring. These systems ensure compliance with regulatory standards and protect the health and safety of both the personnel involved in the compounding process and the patients receiving the medications.

The global Hazardous Drug Compounding Systems revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).

In United States the Hazardous Drug Compounding Systems revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

This report focuses on global and United States Hazardous Drug Compounding Systems market, also covers the segmentation data of other regions in regional level and county level.

The Hazardous Drug Compounding Systems Market is experiencing significant growth driven by the increasing prevalence of chronic diseases and the rising demand for personalized medicine. North America dominates the market due to advanced healthcare infrastructure and stringent regulations ensuring safe drug handling. Europe follows closely, supported by robust pharmaceutical industries, while the Asia-Pacific region is emerging rapidly, propelled by expanding healthcare investments and growing awareness about occupational hazards. Market opportunities abound in technological advancements, such as automated compounding systems that enhance safety and efficiency. However, challenges include high costs of advanced systems, strict regulatory compliance, and the need for specialized training to handle hazardous drugs safely. Addressing these challenges through innovation and education is crucial for sustained market growth.

Hazardous Drug Compounding Systems market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Hazardous Drug Compounding Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.

For United States market, this report focuses on the Hazardous Drug Compounding Systems market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.

MARKET SEGMENTATION

By Company

BD Medical
Equashield
ICU Medical
Simplivia
B. Braun
Baxter
Comecer
Grifols
ARxIUM
NewIcon
Kapsam
Omnicell
QuartetRX

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Sterile Compounding Systems
Non-Sterile Compounding Systems

Segment by Application

Hospital Pharmacies
Outpatient/Community Pharmacies
Research and Development Laboratories
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces Hazardous Drug Compounding Systems definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Detailed analysis of Hazardous Drug Compounding Systems companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Revenue and volume of Hazardous Drug Compounding Systems in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hazardous Drug Compounding Systems sales, revenue, gross margin, and recent development, etc.

Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 12: research findings and conclusion

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Hazardous Drug Compounding Systems Product Introduction

1.2 Global Hazardous Drug Compounding Systems Outlook 2019 VS 2023 VS 2030

1.2.1 Global Hazardous Drug Compounding Systems Sales in US$ Million for the Year 2019-2030

1.2.2 Global Hazardous Drug Compounding Systems Sales in Volume for the Year 2019-2030

1.3 United States Hazardous Drug Compounding Systems Outlook 2019 VS 2023 VS 2030

1.3.1 United States Hazardous Drug Compounding Systems Sales in US$ Million for the Year 2019-2030

1.3.2 United States Hazardous Drug Compounding Systems Sales in Volume for the Year 2019-2030

1.4 Hazardous Drug Compounding Systems Market Size, United States VS Global, 2019 VS 2023 VS 2030

1.4.1 The Market Share of United States Hazardous Drug Compounding Systems in Global, 2019 VS 2023 VS 2030

1.4.2 The Growth Rate of Hazardous Drug Compounding Systems Market Size, United States VS Global, 2019 VS 2023 VS 2030

1.5 Hazardous Drug Compounding Systems Market Dynamics

1.5.1 Hazardous Drug Compounding Systems Industry Trends

1.5.2 Hazardous Drug Compounding Systems Market Drivers

1.5.3 Hazardous Drug Compounding Systems Market Challenges

1.5.4 Hazardous Drug Compounding Systems Market Restraints

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Hazardous Drug Compounding Systems by Type

2.1 Hazardous Drug Compounding Systems Market by Type

2.1.1 Sterile Compounding Systems

2.1.2 Non-Sterile Compounding Systems

2.2 Global Hazardous Drug Compounding Systems Market Size by Type

2.2.1 Global Hazardous Drug Compounding Systems Sales in Value, by Type (2019, 2023 & 2030)

2.2.2 Global Hazardous Drug Compounding Systems Sales in Volume, by Type (2019, 2023 & 2030)

2.2.3 Global Hazardous Drug Compounding Systems Average Selling Price (ASP) by Type (2019, 2023 & 2030)

2.3 United States Hazardous Drug Compounding Systems Market Size by Type

2.3.1 United States Hazardous Drug Compounding Systems Sales in Value, by Type (2019, 2023 & 2030)

2.3.2 United States Hazardous Drug Compounding Systems Sales in Volume, by Type (2019, 2023 & 2030)

2.3.3 United States Hazardous Drug Compounding Systems Average Selling Price (ASP) by Type (2019, 2023 & 2030)

3 Hazardous Drug Compounding Systems by Application

3.1 Hazardous Drug Compounding Systems Market by Application

3.1.1 Hospital Pharmacies

3.1.2 Outpatient/Community Pharmacies

3.1.3 Research and Development Laboratories

3.1.4 Others

3.2 Global Hazardous Drug Compounding Systems Market Size by Application

3.2.1 Global Hazardous Drug Compounding Systems Sales in Value, by Application (2019, 2023 & 2030)

3.2.2 Global Hazardous Drug Compounding Systems Sales in Volume, by Application (2019, 2023 & 2030)

3.2.3 Global Hazardous Drug Compounding Systems Average Selling Price (ASP) by Application (2019, 2023 & 2030)

3.3 United States Hazardous Drug Compounding Systems Market Size by Application

3.3.1 United States Hazardous Drug Compounding Systems Sales in Value, by Application (2019, 2023 & 2030)

3.3.2 United States Hazardous Drug Compounding Systems Sales in Volume, by Application (2019, 2023 & 2030)

3.3.3 United States Hazardous Drug Compounding Systems Average Selling Price (ASP) by Application (2019, 2023 & 2030)

4 Global Hazardous Drug Compounding Systems Competitor Landscape by Company

4.1 Global Hazardous Drug Compounding Systems Market Size by Company

4.1.1 Global Key Manufacturers of Hazardous Drug Compounding Systems, Ranked by Revenue (2023)

4.1.2 Global Hazardous Drug Compounding Systems Revenue by Manufacturer (2019-2024)

4.1.3 Global Hazardous Drug Compounding Systems Sales by Manufacturer (2019-2024)

4.1.4 Global Hazardous Drug Compounding Systems Price by Manufacturer (2019-2024)

4.2 Global Hazardous Drug Compounding Systems Concentration Ratio (CR)

4.2.1 Hazardous Drug Compounding Systems Market Concentration Ratio (CR) (2019-2024)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Hazardous Drug Compounding Systems in 2023

4.2.3 Global Hazardous Drug Compounding Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Manufacturers of Hazardous Drug Compounding Systems, Manufacturing Base Distribution and Headquarters

4.4 Global Key Manufacturers of Hazardous Drug Compounding Systems, Product Offered and Application

4.5 Global Key Manufacturers of Hazardous Drug Compounding Systems, Date of Enter into This Industry

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.7 United States Hazardous Drug Compounding Systems Market Size by Company

4.7.1 Key Players of Hazardous Drug Compounding Systems in United States, Ranked by Revenue (2023)

4.7.2 United States Hazardous Drug Compounding Systems Revenue by Players (2019-2024)

4.7.3 United States Hazardous Drug Compounding Systems Sales by Players (2019-2024)

5 Global Hazardous Drug Compounding Systems Market Size by Region

5.1 Global Hazardous Drug Compounding Systems Market Size by Region: 2019 VS 2023 VS 2030

5.2 Global Hazardous Drug Compounding Systems Market Size in Volume by Region (2019-2030)

5.2.1 Global Hazardous Drug Compounding Systems Sales in Volume by Region: 2019-2024

5.2.2 Global Hazardous Drug Compounding Systems Sales in Volume Forecast by Region (2025-2030)

5.3 Global Hazardous Drug Compounding Systems Market Size in Value by Region (2019-2030)

5.3.1 Global Hazardous Drug Compounding Systems Sales in Value by Region: 2019-2024

5.3.2 Global Hazardous Drug Compounding Systems Sales in Value by Region: 2025-2030

6 Americas

6.1 Americas Hazardous Drug Compounding Systems Market Size YoY Growth 2019-2030

6.2 Americas Hazardous Drug Compounding Systems Sales in Volume, by Type (2019, 2023 & 2030)

6.3 Americas Hazardous Drug Compounding Systems Sales in Volume, by Application (2019, 2023 & 2030)

6.4 Americas Hazardous Drug Compounding Systems Market Facts & Figures by Country (2019, 2023 & 2030)

6.4.1 Americas Hazardous Drug Compounding Systems Sales in Value by Country (2019, 2023 & 2030)

6.4.2 Americas Hazardous Drug Compounding Systems Sales in Volume by Country (2019, 2023 & 2030)

6.4.3 United States

6.4.4 Canada

6.4.5 Mexico

6.4.6 Brazil

7 EMEA

7.1 EMEA Hazardous Drug Compounding Systems Market Size YoY Growth 2019-2030

7.2 EMEA Hazardous Drug Compounding Systems Sales in Volume, by Type (2019, 2023 & 2030)

7.3 EMEA Hazardous Drug Compounding Systems Sales in Volume, by Application (2019, 2023 & 2030)

7.4 EMEA Hazardous Drug Compounding Systems Market Facts & Figures by Country (2019, 2023 & 2030)

7.4.1 EMEA Hazardous Drug Compounding Systems Sales in Value by Country (2019, 2023 & 2030)

7.4.2 EMEA Hazardous Drug Compounding Systems Sales in Volume by Country (2019, 2023 & 2030)

7.4.3 Europe

7.4.4 Middle East

7.4.5 Africa

8 China

8.1 China Hazardous Drug Compounding Systems Market Size YoY Growth 2019-2030

8.2 China Hazardous Drug Compounding Systems Sales in Volume, by Type (2019, 2023 & 2030)

8.3 China Hazardous Drug Compounding Systems Sales in Volume, by Application (2019, 2023 & 2030)

9 APAC

9.1 APAC Hazardous Drug Compounding Systems Market Size YoY Growth 2019-2030

9.2 APAC Hazardous Drug Compounding Systems Sales in Volume, by Type (2019, 2023 & 2030)

9.3 APAC Hazardous Drug Compounding Systems Sales in Volume, by Application (2019, 2023 & 2030)

9.4 APAC Hazardous Drug Compounding Systems Market Facts & Figures by Country (2019, 2023 & 2030)

9.4.1 APAC Hazardous Drug Compounding Systems Sales in Value by Country (2019, 2023 & 2030)

9.4.2 APAC Hazardous Drug Compounding Systems Sales in Volume by Country (2019, 2023 & 2030)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

10 Company Profiles

10.1 BD Medical

10.1.1 BD Medical Company Information

10.1.2 BD Medical Description and Business Overview

10.1.3 BD Medical Hazardous Drug Compounding Systems Sales, Revenue and Gross Margin (2019-2024)

10.1.4 BD Medical Hazardous Drug Compounding Systems Products Offered

10.1.5 BD Medical Recent Development

10.2 Equashield

10.2.1 Equashield Company Information

10.2.2 Equashield Description and Business Overview

10.2.3 Equashield Hazardous Drug Compounding Systems Sales, Revenue and Gross Margin (2019-2024)

10.2.4 Equashield Hazardous Drug Compounding Systems Products Offered

10.2.5 Equashield Recent Development

10.3 ICU Medical

10.3.1 ICU Medical Company Information

10.3.2 ICU Medical Description and Business Overview

10.3.3 ICU Medical Hazardous Drug Compounding Systems Sales, Revenue and Gross Margin (2019-2024)

10.3.4 ICU Medical Hazardous Drug Compounding Systems Products Offered

10.3.5 ICU Medical Recent Development

10.4 Simplivia

10.4.1 Simplivia Company Information

10.4.2 Simplivia Description and Business Overview

10.4.3 Simplivia Hazardous Drug Compounding Systems Sales, Revenue and Gross Margin (2019-2024)

10.4.4 Simplivia Hazardous Drug Compounding Systems Products Offered

10.4.5 Simplivia Recent Development

10.5 B. Braun

10.5.1 B. Braun Company Information

10.5.2 B. Braun Description and Business Overview

10.5.3 B. Braun Hazardous Drug Compounding Systems Sales, Revenue and Gross Margin (2019-2024)

10.5.4 B. Braun Hazardous Drug Compounding Systems Products Offered

10.5.5 B. Braun Recent Development

10.6 Baxter

10.6.1 Baxter Company Information

10.6.2 Baxter Description and Business Overview

10.6.3 Baxter Hazardous Drug Compounding Systems Sales, Revenue and Gross Margin (2019-2024)

10.6.4 Baxter Hazardous Drug Compounding Systems Products Offered

10.6.5 Baxter Recent Development

10.7 Comecer

10.7.1 Comecer Company Information

10.7.2 Comecer Description and Business Overview

10.7.3 Comecer Hazardous Drug Compounding Systems Sales, Revenue and Gross Margin (2019-2024)

10.7.4 Comecer Hazardous Drug Compounding Systems Products Offered

10.7.5 Comecer Recent Development

10.8 Grifols

10.8.1 Grifols Company Information

10.8.2 Grifols Description and Business Overview

10.8.3 Grifols Hazardous Drug Compounding Systems Sales, Revenue and Gross Margin (2019-2024)

10.8.4 Grifols Hazardous Drug Compounding Systems Products Offered

10.8.5 Grifols Recent Development

10.9 ARxIUM

10.9.1 ARxIUM Company Information

10.9.2 ARxIUM Description and Business Overview

10.9.3 ARxIUM Hazardous Drug Compounding Systems Sales, Revenue and Gross Margin (2019-2024)

10.9.4 ARxIUM Hazardous Drug Compounding Systems Products Offered

10.9.5 ARxIUM Recent Development

10.10 NewIcon

10.10.1 NewIcon Company Information

10.10.2 NewIcon Description and Business Overview

10.10.3 NewIcon Hazardous Drug Compounding Systems Sales, Revenue and Gross Margin (2019-2024)

10.10.4 NewIcon Hazardous Drug Compounding Systems Products Offered

10.10.5 NewIcon Recent Development

10.11 Kapsam

10.11.1 Kapsam Company Information

10.11.2 Kapsam Description and Business Overview

10.11.3 Kapsam Hazardous Drug Compounding Systems Sales, Revenue and Gross Margin (2019-2024)

10.11.4 Kapsam Hazardous Drug Compounding Systems Products Offered

10.11.5 Kapsam Recent Development

10.12 Omnicell

10.12.1 Omnicell Company Information

10.12.2 Omnicell Description and Business Overview

10.12.3 Omnicell Hazardous Drug Compounding Systems Sales, Revenue and Gross Margin (2019-2024)

10.12.4 Omnicell Hazardous Drug Compounding Systems Products Offered

10.12.5 Omnicell Recent Development

10.13 QuartetRX

10.13.1 QuartetRX Company Information

10.13.2 QuartetRX Description and Business Overview

10.13.3 QuartetRX Hazardous Drug Compounding Systems Sales, Revenue and Gross Margin (2019-2024)

10.13.4 QuartetRX Hazardous Drug Compounding Systems Products Offered

10.13.5 QuartetRX Recent Development

11 Industry Chain and Sales Channels Analysis

11.1 Hazardous Drug Compounding Systems Industry Chain Analysis

11.2 Hazardous Drug Compounding Systems Key Raw Materials

11.2.1 Key Raw Materials

11.2.2 Raw Materials Key Suppliers

11.3 Hazardous Drug Compounding Systems Production Mode & Process

11.4 Hazardous Drug Compounding Systems Sales and Marketing

11.4.1 Hazardous Drug Compounding Systems Sales Channels

11.4.2 Hazardous Drug Compounding Systems Distributors

11.5 Hazardous Drug Compounding Systems Customers

12 Research Findings and Conclusion

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Hazardous Drug Compounding Systems CAGR in Value, United States VS Global, 2019 VS 2023 VS 2030

Table 2. Hazardous Drug Compounding Systems Market Trends

Table 3. Hazardous Drug Compounding Systems Market Drivers

Table 4. Hazardous Drug Compounding Systems Market Challenges

Table 5. Hazardous Drug Compounding Systems Market Restraints

Table 6. Global Hazardous Drug Compounding Systems Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. United States Hazardous Drug Compounding Systems Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Hazardous Drug Compounding Systems Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 9. United States Hazardous Drug Compounding Systems Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 10. Global Key Manufacturers of Hazardous Drug Compounding Systems, Ranked by Revenue (2023) & (US$ Million)

Table 11. Global Hazardous Drug Compounding Systems Revenue by Manufacturer, (US$ Million) & (2019-2024)

Table 12. Global Hazardous Drug Compounding Systems Revenue Share by Manufacturer, 2019-2024

Table 13. Global Hazardous Drug Compounding Systems Sales by Manufacturer, (Units), 2019-2024

Table 14. Global Hazardous Drug Compounding Systems Sales Share by Manufacturer, 2019-2024

Table 15. Global Hazardous Drug Compounding Systems Price by Manufacturer (2019-2024) & (US$/Unit)

Table 16. Global Hazardous Drug Compounding Systems Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global Hazardous Drug Compounding Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hazardous Drug Compounding Systems as of 2023)

Table 18. Global Key Manufacturers of Hazardous Drug Compounding Systems, Manufacturing Base Distribution and Headquarters

Table 19. Global Key Manufacturers of Hazardous Drug Compounding Systems, Product Offered and Application

Table 20. Global Key Manufacturers of Hazardous Drug Compounding Systems, Date of Enter into This Industry

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Key Players of Hazardous Drug Compounding Systems in United States, Ranked by Revenue (2023) & (US$ million)

Table 23. United States Hazardous Drug Compounding Systems Revenue by Players, (US$ Million) & (2019-2024)

Table 24. United States Hazardous Drug Compounding Systems Revenue Share by Players, (2019-2024)

Table 25. United States Hazardous Drug Compounding Systems Sales by Players, (Units) & (2019-2024)

Table 26. United States Hazardous Drug Compounding Systems Sales Share by Players, (2019-2024)

Table 27. Global Hazardous Drug Compounding Systems Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 28. Global Hazardous Drug Compounding Systems Sales in Volume by Region (2019-2024) & (Units)

Table 29. Global Hazardous Drug Compounding Systems Sales in Volume Forecast by Region (2025-2030) & (Units)

Table 30. Global Hazardous Drug Compounding Systems Sales in Value by Region (2019-2024) & (US$ Million)

Table 31. Global Hazardous Drug Compounding Systems Sales in Value Forecast by Region (2025-2030) & (US$ Million)

Table 32. Americas Hazardous Drug Compounding Systems Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. Americas Hazardous Drug Compounding Systems Sales in Value by Country (2019-2024) & (US$ Million)

Table 34. Americas Hazardous Drug Compounding Systems Sales in Value by Country (2025-2030) & (US$ Million)

Table 35. Americas Hazardous Drug Compounding Systems Sales in Volume by Country (2019-2024) & (Units)

Table 36. Americas Hazardous Drug Compounding Systems Sales in Volume by Country (2025-2030) & (Units)

Table 37. EMEA Hazardous Drug Compounding Systems Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. EMEA Hazardous Drug Compounding Systems Sales in Value by Country (2019-2024) & (US$ Million)

Table 39. EMEA Hazardous Drug Compounding Systems Sales in Value by Country (2025-2030) & (US$ Million)

Table 40. EMEA Hazardous Drug Compounding Systems Sales in Volume by Country (2019-2024) & (Units)

Table 41. EMEA Hazardous Drug Compounding Systems Sales in Volume by Country (2025-2030) & (Units)

Table 42. APAC Hazardous Drug Compounding Systems Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. APAC Hazardous Drug Compounding Systems Sales in Value by Country (2019-2024) & (US$ Million)

Table 44. APAC Hazardous Drug Compounding Systems Sales in Value by Country (2025-2030) & (US$ Million)

Table 45. APAC Hazardous Drug Compounding Systems Sales in Volume by Country (2019-2024) & (Units)

Table 46. APAC Hazardous Drug Compounding Systems Sales in Volume by Country (2025-2030) & (Units)

Table 47. BD Medical Company Information

Table 48. BD Medical Description and Business Overview

Table 49. BD Medical Hazardous Drug Compounding Systems Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 50. BD Medical Hazardous Drug Compounding Systems Product

Table 51. BD Medical Recent Development

Table 52. Equashield Company Information

Table 53. Equashield Description and Business Overview

Table 54. Equashield Hazardous Drug Compounding Systems Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 55. Equashield Hazardous Drug Compounding Systems Product

Table 56. Equashield Recent Development

Table 57. ICU Medical Company Information

Table 58. ICU Medical Description and Business Overview

Table 59. ICU Medical Hazardous Drug Compounding Systems Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. ICU Medical Hazardous Drug Compounding Systems Product

Table 61. ICU Medical Recent Development

Table 62. Simplivia Company Information

Table 63. Simplivia Description and Business Overview

Table 64. Simplivia Hazardous Drug Compounding Systems Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Simplivia Hazardous Drug Compounding Systems Product

Table 66. Simplivia Recent Development

Table 67. B. Braun Company Information

Table 68. B. Braun Description and Business Overview

Table 69. B. Braun Hazardous Drug Compounding Systems Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. B. Braun Hazardous Drug Compounding Systems Product

Table 71. B. Braun Recent Development

Table 72. Baxter Company Information

Table 73. Baxter Description and Business Overview

Table 74. Baxter Hazardous Drug Compounding Systems Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Baxter Hazardous Drug Compounding Systems Product

Table 76. Baxter Recent Development

Table 77. Comecer Company Information

Table 78. Comecer Description and Business Overview

Table 79. Comecer Hazardous Drug Compounding Systems Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Comecer Hazardous Drug Compounding Systems Product

Table 81. Comecer Recent Development

Table 82. Grifols Company Information

Table 83. Grifols Description and Business Overview

Table 84. Grifols Hazardous Drug Compounding Systems Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Grifols Hazardous Drug Compounding Systems Product

Table 86. Grifols Recent Development

Table 87. ARxIUM Company Information

Table 88. ARxIUM Description and Business Overview

Table 89. ARxIUM Hazardous Drug Compounding Systems Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. ARxIUM Hazardous Drug Compounding Systems Product

Table 91. ARxIUM Recent Development

Table 92. NewIcon Company Information

Table 93. NewIcon Description and Business Overview

Table 94. NewIcon Hazardous Drug Compounding Systems Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. NewIcon Hazardous Drug Compounding Systems Product

Table 96. NewIcon Recent Development

Table 97. Kapsam Company Information

Table 98. Kapsam Description and Business Overview

Table 99. Kapsam Hazardous Drug Compounding Systems Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Kapsam Hazardous Drug Compounding Systems Product

Table 101. Kapsam Recent Development

Table 102. Omnicell Company Information

Table 103. Omnicell Description and Business Overview

Table 104. Omnicell Hazardous Drug Compounding Systems Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Omnicell Hazardous Drug Compounding Systems Product

Table 106. Omnicell Recent Development

Table 107. QuartetRX Company Information

Table 108. QuartetRX Description and Business Overview

Table 109. QuartetRX Hazardous Drug Compounding Systems Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. QuartetRX Hazardous Drug Compounding Systems Product

Table 111. QuartetRX Recent Development

Table 112. Key Raw Materials Lists

Table 113. Raw Materials Key Suppliers Lists

Table 114. Hazardous Drug Compounding Systems Distributors List

Table 115. Hazardous Drug Compounding Systems Customers List

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Hazardous Drug Compounding Systems Product Picture

Figure 2. Global Hazardous Drug Compounding Systems Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 3. Global Hazardous Drug Compounding Systems Market Size 2019-2030 (US$ Million)

Figure 4. Global Hazardous Drug Compounding Systems Sales 2019-2030 (Units)

Figure 5. United States Hazardous Drug Compounding Systems Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 6. United States Hazardous Drug Compounding Systems Market Size 2019-2030 (US$ Million)

Figure 7. United States Hazardous Drug Compounding Systems Sales 2019-2030 (Units)

Figure 8. United States Hazardous Drug Compounding Systems Market Share in Global, in Value (US$ Million) 2019-2030

Figure 9. United States Hazardous Drug Compounding Systems Market Share in Global, in Volume (Units) 2019-2030

Figure 10. Hazardous Drug Compounding Systems Report Years Considered

Figure 11. Product Picture of Sterile Compounding Systems

Figure 12. Product Picture of Non-Sterile Compounding Systems

Figure 13. Global Hazardous Drug Compounding Systems Market Share by Type in 2023 & 2030

Figure 14. Global Hazardous Drug Compounding Systems Sales in Value by Type (2019-2030) & (US$ Million)

Figure 15. Global Hazardous Drug Compounding Systems Sales Market Share in Value by Type (2019-2030)

Figure 16. Global Hazardous Drug Compounding Systems Sales by Type (2019-2030) & (Units)

Figure 17. Global Hazardous Drug Compounding Systems Sales Market Share in Volume by Type (2019-2030)

Figure 18. Global Hazardous Drug Compounding Systems Price by Type (2019-2030) & (US$/Unit)

Figure 19. United States Hazardous Drug Compounding Systems Market Share by Type in 2023 & 2030

Figure 20. United States Hazardous Drug Compounding Systems Sales in Value by Type (2019-2030) & (US$ Million)

Figure 21. United States Hazardous Drug Compounding Systems Sales Market Share in Value by Type (2019-2030)

Figure 22. United States Hazardous Drug Compounding Systems Sales by Type (2019-2030) & (Units)

Figure 23. United States Hazardous Drug Compounding Systems Sales Market Share in Volume by Type (2019-2030)

Figure 24. United States Hazardous Drug Compounding Systems Price by Type (2019-2030) & (US$/Unit)

Figure 25. Product Picture of Hospital Pharmacies

Figure 26. Product Picture of Outpatient/Community Pharmacies

Figure 27. Product Picture of Research and Development Laboratories

Figure 28. Product Picture of Others

Figure 29. Global Hazardous Drug Compounding Systems Market Share by Application in 2023 & 2030

Figure 30. Global Hazardous Drug Compounding Systems Sales in Value by Application (2019-2030) & (US$ Million)

Figure 31. Global Hazardous Drug Compounding Systems Sales Market Share in Value by Application (2019-2030)

Figure 32. Global Hazardous Drug Compounding Systems Sales by Application (2019-2030) & (Units)

Figure 33. Global Hazardous Drug Compounding Systems Sales Market Share in Volume by Application (2019-2030)

Figure 34. Global Hazardous Drug Compounding Systems Price by Application (2019-2030) & (US$/Unit)

Figure 35. United States Hazardous Drug Compounding Systems Market Share by Application in 2023 & 2030

Figure 36. United States Hazardous Drug Compounding Systems Sales in Value by Application (2019-2030) & (US$ Million)

Figure 37. United States Hazardous Drug Compounding Systems Sales Market Share in Value by Application (2019-2030)

Figure 38. United States Hazardous Drug Compounding Systems Sales by Application (2019-2030) & (Units)

Figure 39. United States Hazardous Drug Compounding Systems Sales Market Share in Volume by Application (2019-2030)

Figure 40. United States Hazardous Drug Compounding Systems Price by Application (2019-2030) & (US$/Unit)

Figure 41. The Top 5 and 10 Largest Manufacturers of Hazardous Drug Compounding Systems in the World: Market Share by Hazardous Drug Compounding Systems Revenue in 2023

Figure 42. Global Hazardous Drug Compounding Systems Market Size Market Share by Region: 2019 VS 2023 VS 2030

Figure 43. Global Hazardous Drug Compounding Systems Sales in Volume Market Share by Region (2019-2030)

Figure 44. Global Hazardous Drug Compounding Systems Sales in Value Market Share by Region (2019-2030)

Figure 45. Americas Hazardous Drug Compounding Systems Sales in Volume Growth Rate 2019-2030 (Units)

Figure 46. Americas Hazardous Drug Compounding Systems Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 47. Americas Hazardous Drug Compounding Systems Sales by Type (2019-2030) & (Units)

Figure 48. Americas Hazardous Drug Compounding Systems Sales Market Share in Volume by Type (2019-2030)

Figure 49. Americas Hazardous Drug Compounding Systems Sales by Application (2019-2030) & (Units)

Figure 50. Americas Hazardous Drug Compounding Systems Sales Market Share in Volume by Application (2019-2030)

Figure 51. United States Hazardous Drug Compounding Systems Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 52. Canada Hazardous Drug Compounding Systems Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 53. Mexico Hazardous Drug Compounding Systems Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 54. Brazil Hazardous Drug Compounding Systems Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 55. EMEA Hazardous Drug Compounding Systems Sales in Volume Growth Rate 2019-2030 (Units)

Figure 56. EMEA Hazardous Drug Compounding Systems Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 57. EMEA Hazardous Drug Compounding Systems Sales by Type (2019-2030) & (Units)

Figure 58. EMEA Hazardous Drug Compounding Systems Sales Market Share in Volume by Type (2019-2030)

Figure 59. EMEA Hazardous Drug Compounding Systems Sales by Application (2019-2030) & (Units)

Figure 60. EMEA Hazardous Drug Compounding Systems Sales Market Share in Volume by Application (2019-2030)

Figure 61. Europe Hazardous Drug Compounding Systems Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 62. Middle East Hazardous Drug Compounding Systems Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 63. Africa Hazardous Drug Compounding Systems Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 64. China Hazardous Drug Compounding Systems Sales in Volume Growth Rate 2019-2030 (Units)

Figure 65. China Hazardous Drug Compounding Systems Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 66. China Hazardous Drug Compounding Systems Sales by Type (2019-2030) & (Units)

Figure 67. China Hazardous Drug Compounding Systems Sales Market Share in Volume by Type (2019-2030)

Figure 68. China Hazardous Drug Compounding Systems Sales by Application (2019-2030) & (Units)

Figure 69. China Hazardous Drug Compounding Systems Sales Market Share in Volume by Application (2019-2030)

Figure 70. APAC Hazardous Drug Compounding Systems Sales in Volume Growth Rate 2019-2030 (Units)

Figure 71. APAC Hazardous Drug Compounding Systems Sales in Value Growth Rate 2019-2030 (US$ Million)

Figure 72. APAC Hazardous Drug Compounding Systems Sales by Type (2019-2030) & (Units)

Figure 73. APAC Hazardous Drug Compounding Systems Sales Market Share in Volume by Type (2019-2030)

Figure 74. APAC Hazardous Drug Compounding Systems Sales by Application (2019-2030) & (Units)

Figure 75. APAC Hazardous Drug Compounding Systems Sales Market Share in Volume by Application (2019-2030)

Figure 76. Japan Hazardous Drug Compounding Systems Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 77. South Korea Hazardous Drug Compounding Systems Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 78. China Taiwan Hazardous Drug Compounding Systems Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 79. Southeast Asia Hazardous Drug Compounding Systems Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 80. India Hazardous Drug Compounding Systems Sales in Value Growth Rate (2019-2030) & (US$ Million)

Figure 81. Hazardous Drug Compounding Systems Value Chain

Figure 82. Hazardous Drug Compounding Systems Production Process

Figure 83. Channels of Distribution (Direct Vs Distribution)

Figure 84. Bottom-up and Top-down Approaches for This Report

Figure 85. Data Triangulation

Figure 86. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Hazardous Drug Compounding Systems market? zhanKai

The top companies in the global Hazardous Drug Compounding Systems market are BD Medical、Equashield、ICU Medical.

Related Reports

Global Hazardous Drug Compounding Systems Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hazardous Drug Compounding Systems market is projected to grow from US$ 4125 million in 2025 to US$ 6761 million by 2032, at a CAGR of 7.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 171
USD 4900.00
(Single User License)
Global Hazardous Drug Compounding Systems Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hazardous Drug Compounding Systems market size was US$ 4125 million in 2025 and is forecast to reach a readjusted size of US$ 6761 million by 2032 with a CAGR of 7.3% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 106
USD 4250.00
(Single User License)
Global Hazardous Drug Compounding Systems Market Research Report 2026
The global Hazardous Drug Compounding Systems market was valued at US$ 4125 million in 2025 and is anticipated to reach US$ 6761 million by 2032, at a CAGR of 7.3% from 2026 to 2032.
Published Date: 2026-02-13
Pages: 130
USD 2900.00
(Single User License)
Hazardous Drug Compounding Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hazardous Drug Compounding Systems was estimated to be worth US$ 4125 million in 2025 and is projected to reach US$ 6761 million, growing at a CAGR of 7.3% from 2026 to 2032.
Published Date: 2026-02-13
Pages: 140
USD 3950.00
(Single User License)
Global Hazardous Drug Compounding Systems Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hazardous Drug Compounding Systems market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 160
USD 4900.00
(Single User License)
Global Hazardous Drug Compounding Systems Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hazardous Drug Compounding Systems market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 100
USD 4250.00
(Single User License)
Hazardous Drug Compounding Systems - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hazardous Drug Compounding Systems was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 126
USD 3950.00
(Single User License)
Global Hazardous Drug Compounding Systems Market Research Report 2025
The global market for Hazardous Drug Compounding Systems was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 94
USD 2900.00
(Single User License)
Global Hazardous Drug Compounding Systems Market Research Report 2024
Hazardous Drug Compounding Systems refer to specialized procedures, equipment, and facilities designed to safely handle, prepare, and store medications classified as hazardous. These systems are crucial in healthcare settings, such as pharmacies and hospitals, where potent drugs like chemotherapy agents, antivirals, hormones, and other medications that pose significant risks to health workers and patients are prepared. The primary goal is to minimize exposure to these dangerous substances through stringent controls and protocols, including the use of ventilated cabinets, closed-system transfer devices, personal protective equipment, and rigorous environmental monitoring. These systems ensure compliance with regulatory standards and protect the health and safety of both the personnel involved in the compounding process and the patients receiving the medications.
Published Date: 2024-08-03
Pages: 89
USD 2900.00
(Single User License)
Global Hazardous Drug Compounding Systems Market Insights, Forecast to 2030
Hazardous Drug Compounding Systems refer to specialized procedures, equipment, and facilities designed to safely handle, prepare, and store medications classified as hazardous. These systems are crucial in healthcare settings, such as pharmacies and hospitals, where potent drugs like chemotherapy agents, antivirals, hormones, and other medications that pose significant risks to health workers and patients are prepared. The primary goal is to minimize exposure to these dangerous substances through stringent controls and protocols, including the use of ventilated cabinets, closed-system transfer devices, personal protective equipment, and rigorous environmental monitoring. These systems ensure compliance with regulatory standards and protect the health and safety of both the personnel involved in the compounding process and the patients receiving the medications.
Published Date: 2024-08-03
Pages: 152
USD 4900.00
(Single User License)

Global Hazardous Drug Compounding Systems Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hazardous Drug Compounding Systems market is projected to grow from US$ 4125 million in 2025 to US$ 6761 million by 2032, at a CAGR of 7.3% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 171
USD 4900.00 (Single User License)
Global Hazardous Drug Compounding Systems Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hazardous Drug Compounding Systems market size was US$ 4125 million in 2025 and is forecast to reach a readjusted size of US$ 6761 million by 2032 with a CAGR of 7.3% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 106
USD 4250.00 (Single User License)
Global Hazardous Drug Compounding Systems Market Research Report 2026
The global Hazardous Drug Compounding Systems market was valued at US$ 4125 million in 2025 and is anticipated to reach US$ 6761 million by 2032, at a CAGR of 7.3% from 2026 to 2032.
Published: 2026-02-13
Pages: 130
USD 2900.00 (Single User License)
Hazardous Drug Compounding Systems- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hazardous Drug Compounding Systems was estimated to be worth US$ 4125 million in 2025 and is projected to reach US$ 6761 million, growing at a CAGR of 7.3% from 2026 to 2032.
Published: 2026-02-13
Pages: 140
USD 3950.00 (Single User License)
Global Hazardous Drug Compounding Systems Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hazardous Drug Compounding Systems market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 160
USD 4900.00 (Single User License)
Global Hazardous Drug Compounding Systems Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hazardous Drug Compounding Systems market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 100
USD 4250.00 (Single User License)
Hazardous Drug Compounding Systems - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hazardous Drug Compounding Systems was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 126
USD 3950.00 (Single User License)
Global Hazardous Drug Compounding Systems Market Research Report 2025
The global market for Hazardous Drug Compounding Systems was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 94
USD 2900.00 (Single User License)
Global Hazardous Drug Compounding Systems Market Research Report 2024
Hazardous Drug Compounding Systems refer to specialized procedures, equipment, and facilities designed to safely handle, prepare, and store medications classified as hazardous. These systems are crucial in healthcare settings, such as pharmacies and hospitals, where potent drugs like chemotherapy agents, antivirals, hormones, and other medications that pose significant risks to health workers and patients are prepared. The primary goal is to minimize exposure to these dangerous substances through stringent controls and protocols, including the use of ventilated cabinets, closed-system transfer devices, personal protective equipment, and rigorous environmental monitoring. These systems ensure compliance with regulatory standards and protect the health and safety of both the personnel involved in the compounding process and the patients receiving the medications.
Published: 2024-08-03
Pages: 89
USD 2900.00 (Single User License)
Global Hazardous Drug Compounding Systems Market Insights, Forecast to 2030
Hazardous Drug Compounding Systems refer to specialized procedures, equipment, and facilities designed to safely handle, prepare, and store medications classified as hazardous. These systems are crucial in healthcare settings, such as pharmacies and hospitals, where potent drugs like chemotherapy agents, antivirals, hormones, and other medications that pose significant risks to health workers and patients are prepared. The primary goal is to minimize exposure to these dangerous substances through stringent controls and protocols, including the use of ventilated cabinets, closed-system transfer devices, personal protective equipment, and rigorous environmental monitoring. These systems ensure compliance with regulatory standards and protect the health and safety of both the personnel involved in the compounding process and the patients receiving the medications.
Published: 2024-08-03
Pages: 152
USD 4900.00 (Single User License)